US 4,822,368 AGrant
Sugical Method of Attaching Enclosure Member for Prosthetic Joint
Issue Date:1989-04-18
•10 Claims
•3 Drawing Sheets
Abstract
A flexible enclosure is applied to a prosthetic joint to isolate wear particles which are produced by interengagement between the components of the joint. The enclosure overlies the joint, and is sealingly affixed to the respective joint components proximate to its ends. The enclosure may be impermeable to fluids and contain a synthetic synovial fluid for lubrication of the joint. Alternatively, the enclosure may be porous having pores of a size ranging between 0.1 and 100 microns across so as to maintain larger wear particles which the body cannot assimilate.
Metadata
Assignee
- Boehringer Mannheim Corporation
Inventor
- John P. Collier
Application Information
Application Number:US 1442635
Filing Date:1988-01-13
Priority Date:1986-06-02
Art Unit:332
Classifications
IPC:
A61F 232
Field of Search:
62316;18;19;20;21;22;23
Patent Drawings (3 sheets)
Description
The present invention relates generally to the field of orthopedic surgery and has particular application to a total artificial joint and the implantation thereof.
II. Description of the Prior Art
This invention relates broadly to means for transferring forces imposed on load bearing portions of artificial joints to bone in humans and animals. While the present invention is applicable for use with implants of various types and in numerous applications in human and animal joints, it will be described herein, for purposes of example only, as being specifically adapted for use in transferring the load on the femoral head replacement of a total hip joint prosthesis, such as the Charnley type, to the femur. Although hip prostheses will be used for illustrative purposes only, features of the invention will be stated in a generic form so that they are applicable to all joint prostheses and to the geometric and biomedical properties of all animal and human joints.
The artificial hip joint is intended as a replacement for both parts of the human hip joint. The natural hip joint consists of a ball-like member at the head of the femur or thighbone, this member being rotatable in a socket, termed the acetabulum, in the pelvis. When this joint becomes damaged or diseased, it is the practice to replace the femoral head with a prosthesis including a ball member attached to the femur by a neck and stem which fits into the medullary canal, and to fit a corresponding artificial socket member into the acetabulum, which may be suitably enlarged for the purpose.
Most of the currently available total joint replacements are comprised of a metal component articulating against a plastic component. For example, the spherical articulating, or bearing, surfaces of the typical prosthetic hip joint include an implanted femoral component having a spherical surface of cobalt/chromium alloy articulating against an acetabular component, or cup, made of high-density polyethylene.
In the late 1960's , Sir John Charnley experimented with the use of tetrafluoroethylene, commonly known by the trademark Teflon, for the surface of the acetabular component, working against the usual metal component, but the results were less than satisfactory. While Teflon material in its bulk form is inert in the body, the Teflon wear debris generated by the articulating surfaces rubbing against one another caused severe histiocytic reactions in the surrounding tissue with resulting trauma and pain experienced by the patient.
The reaction was such that the Teflon components eventually required removal.
More recent hip prostheses have utilized acetabular sockets of high density polyethylene, and it has been the practice to utilize a bone cement, polymethyl methacrylate, for example, to retain the implanted component. There is some uncertainty as to which of the two polymeric materials has been the major source of wear particles that have caused observed adverse tissue reactions, although it has generally been assumed to be the bone cement.
As the technology has progressed, porous coatings have begun to replace bone cement in a high proportion of implantations. This permits natural bone ingrowth, eliminating the need for bone cement and avoiding problems caused by the cementitious wear particles. This new technology has not been in use long enough to determine the extent of problems resulting from wear particles resulting from the interaction between the metal component and the plastic component. However, as prostheses remain in use for longer periods and are used for younger and more active patients, it is inevitable that wear particles from the polyethylene articulating surfaces will become a problem. Hence some means of isolating these particles from the surrounding cellular tissue would be highly beneficial.
For example, there is a substantial and growing body of evidence to the effect that wear particles lead to prosthetic loosening and eventually to catastrophic failure of the prosthesis. In a paper published in the American Volume of The Journal of Bone and Joint Surgery, Vol. 65-A, No. 5 (June 1983) on page 575, Goldring et al state:
"CLINICAL RELEVANCE: This transformation of tissue at the bone-cement interface in patients with a non-septic, loose total hip component to a synovial-like tissue with the capacity to generate 10 prostaglandin E.sub.2 and collagenase may explain the progressive lysis of bone that is seen in some patients with loose cemented total joint implants. Loosening of the component may be a stimulus to the synthetic activity of this tissue, which leads 15 to further resorption of bone. Understanding and the possibility of pharmacological control of this membrane may contribute to improved duration of total joint implants."
It was with knowledge of the current state of the art and in view of the problems previously encountered as noted above, that the present invention was conceived and has now been reduced to practice.
Summary of the Invention
The present invention pertains to implanted total prosthetic joints such as hips and knees and a primary object of the invention is to isolate the joint from its surrounding tissue by enclosing it within a flexible member, thereby preventing wear particles from causing histiocytic reactions in the surrounding tissue. It is proposed to provide, as a permanent part of the prosthetic joint an enclosure of flexible, biologically compatible material which is attached to each component of a prosthetic joint and which isolates the joint from its surrounding tissue. For example in the hip prosthesis, one end of the enclosure would be attached to the femoral component and the other end to the acetabular component, the enclosure material being flexible enough so that it does not impair maximum normal joint motion. Examples of such suitable biocompatible materials include silicone rubber and woven polymers such as those commonly sold under the trademarks Gortex and Dacron which are used in prosthetic venous grafts.
The enclosure would not only avoid adverse tissue reactions by preventing wear particles from entering the surrounding tissue but in one embodiment, it would also permit the use within the enclosure of a lubricating fluid with properties optimized for the articulating materials used, rather than depending on the less than ideal properties of body fluid present after the natural synovial fluid has been removed during the joint implantation surgery. In this instance, it would be impervious to fluid. Silicone rubber would be an excellent choice of material for this application. This would greatly reduce the production of wear particles and increase the life of the joint. In another embodiment, using Gortex or an equivalent porous material or fabric or a semi-permeable, membrane, it would permit the passage of body fluids therethrough while preventing wear particles greater than a predetermined size to escape to the rest of the body. Being transparent to X-ray in either event, the enclosure would not interfere in any way with routine examinations of the joint.
Other and further features, objects, advantages, and benefits of the invention will become apparent from the following description taken in conjunction with the following drawings. It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory but not restrictive of the invention. The accompanying drawings which are incorporated in and constitute a part of this invention, illustrate some of the embodiments of the invention and, together with the description, serve to explain the principles of the invention in general terms. Like numerals refer to like parts throughout the disclosure.
Brief Description of the Drawings
FIG. 1 is a detail elevation view diagrammatically illustrating a natural hip joint;
FIG. 2 is a partly sectioned elevation view diagrammatically illustrating a total hip replacement incorporating the invention;
FIG. 3 is an enlarged detail elevation view of parts illustrated in FIG. 2 with additional portions being cut away and in section;
FIG. 4 is a detail perspective exploded view of parts illustrated in FIGS. 2 and 3;
FIG. 5 is a perspective exploded view illustrating another embodiment of the invention; and
FIG. 6 is a side elevation view of the parts illustrated in FIG. 5 but in their assembled condition.
Detailed Description of the Preferred Embodiment
Turn now to the drawings which illustrate the invention as applied to a reconstructed hip joint which may be that of an animal or of a human being. The hip joint is chosen for illustration for simplicity's sake since it is probably the easiest joint to visualize. It will be understood, however, that the invention can be utilized at any major joint of the body whether it be hip, knee, elbow, shoulder, wrist, or the like.
A natural hip joint 20, as illustrated in FIG. 1, is a ball-in-socket joint wherein the head 22 is connected to the shaft 24 of the femur 26 by means of a neck 28. The head 22 is generally of hemispherical shape and rotatably engaged with the acetabulum 30 of the pelvis 32. When the hip joint 20 becomes damaged or diseased, it may become desirable to replace elements of the structure just described. Such an artificial structure is illustrated in FIGS. 2-4 and its emplacement is performed by means of a surgical procedure. Specifically, with the patient under anesthethic, and with the hip joint exposed, the femoral head 22 is separated from the acetabulum 30. A reamer or similar bone cutting tool is utilized to reshape the acetabulum to complimentarily receive an acetabular component 34 which has a spherical inner surface 36. The acetabular component 34 is suitably attached to the pelvis 32 so that it does not rotate or otherwise move relative to the hip bone.
As to the femur 26, the head 22 and at least a portion of the neck 28 are surgically removed from the shaft 24. Thereupon, a complimentary part of the prosthesis, namely a femoral component 38, is secured to the femur 26. Specifically, the femoral component 38 includes a shank 40, a ball 42, a neck 44 intermediate the ball and the shank, and often a collar 46 carried at an expanded end of the shank 40. The ball 42 has a spherical surface 48. The femoral component 38 is then inserted into the femur 26 with the shank 40 of the component 38 being driven downwardly through the approximate center of the shaft 24 of the femur 26 until the collar 46 is brought into contact with a resected medial neck 50 of the femur. The ball 42 is designed to have a slightly smaller radius than that of the inner surface 36 of the acetabular component 34. The spherical surface 48 and the inner surface 36 are polished such that when the ball 42 is received within the acetabular component 34 is illustrated in FIGS. 2 and 3, the ball is free to rotate relative to the acetabular component with a minimum of friction. Typically at the present time, the acetabular component 34 is composed of a bearing portion 34a composed of an inert plastic material such as high density polyethylene, and an outer cup-shaped support member 34b composed of suitable metal such as a cobalt alloy or a titanium alloy. The femoral component 38 is formed of a hard, biologically acceptable metal, such as a cobalt-chromium-molybdenum alloy or a titanium alloy.
As seen in FIGS. 2 and 3, the invention comprises a sheath 54 of a flexible, biologically inert material having a thickness generally in the range of 20 microns to one millimeter. The sheath is generally tubular in shape, one end 56 being affixed and sealed to a terminal lip 58 of the acetabular component 34. An opposite end 60 of the sheath 54 is affixed and sealed to the outer surface of the femoral component 38 adjacent the neck 44 or the collar 40. The ends of the sheath 54 may be sealingly affixed or engaged by means of a suitable adhesive, or by mechanical or frictional bonding as in the event the sheath is composed of a heat shrinkable material, or in any other suitable fashion. One such other suitable method is illustrated in FIGS. 2 and 3 according to which suitable elongate material 62 such as suture or wire encircles the sheath 54 proximate to its ends. Proximate to the end 60, the elongate material encircles the sheath in the region of the neck 44 where it secures the sheath to a groove 45. Proximate to the end 56, the elongate material encircles the sheath, preferably with the aid of an annular groove 64 formed near the base of the acetabular component 34.
The sheath may be porous or non-porous, depending upon whether it is desired to have body fluids able to move in and out of the joint. If it is porpous, it may be fabricated of a material such as Gortex or woven Dacron having pores which are sufficiently small that wear debris cannot pass out of the articulating joint and into the host tissue where it could cause an inflammatory response and lead to prosthetic loosening. In this instance, the size of the pores could be in the range of 0.1 to 100 microns, but would preferably be in the range of 1 to 10 microns. The rationale for this is that the lymph system of the body can properly dispose of small amounts of very small wear particles. Above this size range, the particles can cause problems having the nature of causing inflamation and possibly loosening of the prosthetic appliance.
It was also noted that the sheath 54 could be nonpermeable and, in that instance, a suitable material for its composition would be silicone rubber. In that instance, it would be desirable to fill the joint space enclosed by the sheath with a suitable liquid, such as a sterile saline solution or other replacement of the synovial fluid, and thereby potentially improve the lubrication of the joint while at the same time maintaining the wear debris from the joint within the synovial sheath 54.
It is intended that the sheath 54 in no way constrain the motion between the articulating surfaces as represented by the acetabular component 34 and the femoral component 38.
It is also envisioned as quite possible in either instance, after considerable wear has occurred, that the wear particles could be aspirated from the joint using conventional techniques. One typical technique requires concentric hollow tubes, one of which provides fresh saline solution or its equivalent, to the joint, and the other provides an exit for the wear debris. Additionally, in the event the polyethylene insert becomes worn out, the sheath 54 can be temporarily disconnected, the old polyethylene insert replaced with a new one, the wear particles removed, and the sheath re-attached.
Another embodiment of the invention is presented in FIGS. 5 and 6 which illustrate a flexible enclosure construction 66 which, by way of example, is utilized in conjunction with a hip prosthesis. In this instance, the acetabular component 34 may be substantially the same as that previously described. However, the femoral component 68 is somewhat modified. As previously, the femoral component includes a shank 70 and a modular head system comprising a ball 72 and a neck 74 formed, for example, with a so-called Morse taper according to a commonly used arrangement. The ball 72 is hollowed-out as at 76 and is mounted on the neck 74 by way of a force fit.
In this instance, prior to mounting of the ball 72 on the neck 74, a flexible, generally ring like enclosure member 78 is mounted onto the neck 74. In order to accomplish this construction, the enclosure member 78 is provided with an axial bore 80 which extends entirely through the member and is of a size to assure a tight fit with the neck 74. The enclosure member 78 may be composed of the same materials mentioned previously with respect to the sheet 54. The enclosure member 78 is also formed with a continuous peripheral edge 82 which is generally sized and shaped in a complementary fashion with respect to a rim 84 on the acetabular component 34. Thus, when the prosthesis, as modified by this embodiment of the invention, assumes its completed form as illustrated in FIG. 6, the peripheral edge 82 matingly engages the rim 84 of the acetabular component 34. This mating engagement is intended to be a sealing engagement. That is, with the construction illustrated in FIG. 6, the support member 34b (as illustrated in FIG. 3) and the enclosure member 78, acting together, serve to isolate the inter-engaging region of the acetabular component and of the femoral component from the remainder of the body.
It will be appreciated that the enclosure member 78 must be sufficiently flexible to permit the full range of normal motion between the acetabular component and the femoral component as in the embodiment using the sheath 54. Also, the sealing engagement between the enclosure member and the acetabular component may be of any suitable nature including, but not necessarily limited to, bonding by use of adhesives, or otherwise, mounting by way of a friction fit, or by a mechanical connection as by the use of suture or wire.
The invention, then, recognizes substantial evidence to the effect that the plastic wear particles within the tissue of humans causes the formation of prostaglandins which have been associated with the fibrous membranes surrounding loosened prostheses of all types. Furthermore, it is believed that the wear debris causes, at least in part, the loosening of prostheses. It is recognized as being very difficult to reduce the wear generated by metal on plastic articulating surfaces. Nevertheless, it should be possible to keep the wear particles generated by such articulation away from the host tissue. Indeed, that is what has been described herein, namely, a barrier between the articulating surfaces and the host to keep all wear debris contained and away from the host tissue.
While the preferred embodiments of the invention have been disclosed in detail, it should be understood by those skilled in the art that various modifications may be made to the illustrated embodiments without departing from the scope as described in the specification and defined in the appended claims.
Claims
What is claimed is:
1. A method of providing an artificial joint for a patient comprising the steps of: (a) separating the head of a patient's femur from the patient's pelvic acetabulum; (b) providing an artificial acetabular component having a hemispheric shaped inner surface terminating at a rim thereby defining a socket; (c) reshaping the acetabulum of the patient to form a recess to fittingly receive said acetabular component; (d) mounting said acetabular component within the recess of said acetabulum; (e) surgically removing the head of the patient's femur from the shaft of the femur; (f) providing an artificial femoral component having a shank carrying a ball member slightly smaller than the socket of the acetabular component, a neck region joining the ball member and the shank having a cross section smaller than either the ball member or the shank; (g) anchoring the shank in the femoral shaft with the femoral ball member projecting from the end of the femoral component; (h) fitting the ball member into the socket of the acetabular component so as to be rotatable therein; (i) isolating the interengaging surfaces of the ball member and the socket from the reminder of the patient's body, including the steps of: (j) providing a generally tubular flexible sheath having first and second ends; (k) receiving the sheath over the femoral ball member; (l) sealingly affixing the first end of the sheath to the neck region; and (m) sealingly affixing the second end of the sheath of the rim of the acetabular component.
2. A method as set forth in claim 1 wherein steps (f), (g), and (h) precede steps (b), (c), and (d).
3. A method as set forth in claim 1 wherein the sheath is impermeable to fluids and including the step of: (n) filling the cavity defined by the socket, the head member, and the sheath with a sterile lubricating biocompatible fluid.
4. A method as set forth in claim 3 wherein: the sterile lubricating biocompatible fluid is a saline solution.
5. A method as set forth in claim 1 wherein: the sheath is porous having pores of a size less than 10 microns across.
6. A method of providing an artificial joint for a patient comprising the steps of: (a) removing a first natural interengaging surface from a first bone of the patient; (b) replacing the first natural interengaging surface with a first member having a first artificial interengaging surface; (c) removing from a second bone of the patient a second natural interengaging surface which normally cooperatively engages with the first natural interengaging surface to permit relative movement between the first and second bones; (d) replacing the second natural interengaging surface with a second member having a second artificial interengaging surface; and (e) isolating the first and second artificial interengaging surfaces from the remainder of the patient's body, including the steps of: (f) providing a generally tubular flexible sheath having first and second ends; (g) receiving the sheath over the first and second interengaging surfaces; (h) sealingly affixing the first end of the sheath to the first artificial member; and (i) sealingly affixing the second end of the sheath to the second artificial member.
7. A method as set forth in claim 6 wherein the sheath is impermeable to fluids and including the step of: (j) filling the cavity defined by the first and second artificial members and the sheath with a sterile lubricating biocompatible fluid.
8. A method as set forth in claim 7 wherein: the sterile lubricating biocompatible fluid is a saline solution.
9. A method as set forth in claim 8 wherein: the sheath is porous having pores of a size less than 10 microns across.
10. A method of providing an artificial joint for a patient comprising the steps of: (a) separating the head of a patient's femur from the patient's pelvic acetabulum; (b) providing an artificial acetabular component having a hemispheric shaped inner surface terminating at a rim thereby defining a socket; (c) reshaping the acetabulum of the patient to form a recess to fittingly receive said acetabular component; (d) mounting said acetabular component within the recess of said acetabulum; (e) surgically removing the head of the patient's femur from the shaft of the femur; (f) providing an artificial femoral component having a shank adapted to carry a ball member slightly smaller than the socket of the acetabular component and terminating at a neck region having across section smaller than either the ball member or the shank; (g) anchoring the shank in the femoral shaft with the neck region projecting from the end of the femoral component; (h) sealingly affixing a flexible ring-shaped enclosure member with a peripheral edge on the femoral component such that the shank extends fittingly through an axial bore in the ring-shaped member; (i) mounting the ball member onto the neck region of the femoral component; (j) fitting the ball member into the socket of the acetabular component so as to be rotatable therein; and (k) sealingly engaging the peripheral edge of the ring-shaped enclosure member with the rim of the acetabular component thereby isolating the interengaging surfaces of the ball member and the socket from the remainder of the patient's body.
Patent Citations (5)
| Patent | Date | Inventor | Cited By |
|---|---|---|---|
| US3506982 | 1970-04-01 | Steffee | |
| US3739403 | 1973-06-01 | Nicolle | |
| US3760427 | 1973-09-01 | Schultz | |
| US3864758 | 1975-02-01 | Yakich | |
| US3990116 | 1976-11-01 | Fixel et al. |